NCT02902367

Brief Summary

Eighty community-living individuals in Uppsala municipality will be included. Intervention: Outdoor walking exercise program and one strength exercise. Methods: Clinical assessments, questionnaires and medical records. Assessment of motor function, cognition, level of physical activity, food intake and perceived stress are performed at screening as baseline measurements. Walking capacity, mobility, handgrip strength, body composition and cardiovascular risk markers will be assessed at baseline and after 12 week of training. At one year after training health-related quality of life, another cardiovascular incidence and mortality will be documented.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
80

participants targeted

Target at P50-P75 for not_applicable

Timeline
Completed

Started Nov 2016

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

September 11, 2016

Completed
4 days until next milestone

First Posted

Study publicly available on registry

September 15, 2016

Completed
2 months until next milestone

Study Start

First participant enrolled

November 1, 2016

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2018

Completed
7 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2018

Completed
Last Updated

September 19, 2017

Status Verified

September 1, 2017

Enrollment Period

1.3 years

First QC Date

September 11, 2016

Last Update Submit

September 17, 2017

Conditions

Keywords

mobilityexercisewalking capacityfat massmuscles

Outcome Measures

Primary Outcomes (1)

  • 6 minute walk test (6MWT)

    walking capacity

    from baseline walking capacity to three months

Secondary Outcomes (11)

  • Short Physical Performance Battery (SPPB)

    from baseline SPPB to three months

  • 10 meter walk test (10mWT)

    from baseline 10mWT to three months

  • Hand-dynamometer (Jamar)

    from baseline Jamar to three months

  • Body composition (bioelectric impedance analysis)

    from baseline body composition to three months

  • Cardiometabolic risk markers

    from baseline cardiometabolic risk markers to three months

  • +6 more secondary outcomes

Study Arms (2)

Intervention:

EXPERIMENTAL

Outdoor walking and strength exercise, Three months, daily SMS.

Other: Outdoor walking and strength exercise

Control group

OTHER

Usual care; no restriction for exercise, Three months

Other: control group

Interventions

Exercise group: Participants are supposed to perform an outdoor walking exercise program and one strength exercise for 12 weeks. The first 2 weeks start with daily walks. The intensity and frequency of walks will progressively increase performed according to the Borg scale: 12-15, ie, moderate to strenuous. Participants will walk 5-7 days/week. Added to this is a strength exercise, i.e. chair-rising which also should be performed daily.

Also known as: exercise
Intervention:

Control-Group: Treatment as usual for 12 weeks, without restriction of being physically active.

Also known as: control
Control group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Verified ischemic cerebral infarction or intracerebral hemorrhage.
  • Sufficient walking capacity and motor function
  • Able to communicate in Swedish
  • Signed consent

You may not qualify if:

  • One or more of the following:
  • Subarachnoid bleeding
  • Insufficient cognition and impaired ability to understand instructions
  • Medical problems that make it unsuitable to participate
  • Pacemaker (body composition measurements)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Birgit Vahlberg

Uppsala, 75185, Sweden

RECRUITING

Related Publications (3)

  • Vahlberg BM, Eriksson S, Holmback U, Lundstrom E. Factors associated with changes in walking performance in individuals 3 months after stroke or TIA: secondary analyses from a randomised controlled trial of SMS-delivered training instructions in Sweden. BMJ Open. 2024 Mar 4;14(3):e078180. doi: 10.1136/bmjopen-2023-078180.

  • Vahlberg BM, Lundstrom E, Eriksson S, Holmback U, Cederholm T. Potential effects on cardiometabolic risk factors and body composition by short message service (SMS)-guided training after recent minor stroke or transient ischaemic attack: post hoc analyses of the STROKEWALK randomised controlled trial. BMJ Open. 2021 Oct 18;11(10):e054851. doi: 10.1136/bmjopen-2021-054851.

  • Vahlberg B, Lundstrom E, Eriksson S, Holmback U, Cederholm T. Effects on walking performance and lower body strength by short message service guided training after stroke or transient ischemic attack (The STROKEWALK Study): a randomized controlled trial. Clin Rehabil. 2021 Feb;35(2):276-287. doi: 10.1177/0269215520954346. Epub 2020 Sep 18.

MeSH Terms

Conditions

StrokeIschemic Attack, TransientMotor Activity

Interventions

ExerciseControl Groups

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesBrain IschemiaBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaEpidemiologic Research DesignEpidemiologic MethodsInvestigative TechniquesResearch DesignMethods

Study Officials

  • Birgit Vahlberg

    Sweden,Uppsala Uppsala University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Birgit Vahlberg, Med Dr, RPT

CONTACT

Tommy Cederholm, Professor,MD

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER GOV
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Md Dr, RPT

Study Record Dates

First Submitted

September 11, 2016

First Posted

September 15, 2016

Study Start

November 1, 2016

Primary Completion

March 1, 2018

Study Completion

October 1, 2018

Last Updated

September 19, 2017

Record last verified: 2017-09

Locations